KYLAMI, created in 2007 (Japan), from 440 sister brands and 4958 competing brands. The KYLAMI brand is owned by Takeda Pharmaceutical, a company listed in Francfort. The International Securities Identification Number (ISIN) of Takeda Pharmaceutical is JP3463000004. KYLAMI belongs to the Drug Manufacturers business sector.